Philips Signs Multiyear Strategic Partnership Agreement for Connected Care Solutions with 28-hospital Dutch SAZ Group

February 4, 2021

Philips notes the partnership will encompass the monitoring, observation and self-management of patients throughout the entire care journey, both inside and outside the hospitals, supported by Philips advanced patient monitoring and population health management solutions.

“The SAZ unites 28 regional hospitals, which are together making the move from being hospitals to a health organization,” says Bert Kleinlugtenbeld, President of the SAZ. “In doing so, the strength of the SAZ is that we act together and learn from each other. Our strategic direction is to move care to the patient’s home wherever possible. We also see an important role for prevention. In making this move, removing the burden from the patient and the care provider is central. With Philips, we will do this by using the latest technological innovations in the field of patient monitoring and population health management, strengthening our cooperation in patient-centric care.”

“We look forward to continue working with the regional SAZ hospitals to provide the right care in the right place,” says Léon Kempeneers, General Manager Health Systems Philips Benelux. “Through this collaboration with the SAZ, our connected care solutions can be scaled up more easily within the Netherlands’ regional hospitals. Our goal is to improve care by using technology to relieve the burden on patients and caregivers. By improving outcomes through the early detection of patient deteriorations and reducing readmissions, we ultimately hope to reduce the pressure on staff.”

Prevent ICU re-admissions

During the course of 2021 about ten SAZ hospitals will start the collaboration focused either on hospital care or care in the community. In-hospital applications will include early detection of patient deterioration on nursing wards using Philips’ IntelliVue Guardian Solution, which the Bravis hospital in Bergen op Zoom and Roosendaal, the Netherlands, already has experience of using. The Bravis hospital is also already using Philips’ wearable biosensor and will use it to make a better connection between patient monitoring in the hospital’s ICU and its nursing wards, reducing the length of stay in the ICU and helping to prevent ICU re-admissions. In addition, the solution will help a patient to return to a long term care setting or their own home. By creating an automatic link between the Philips biosensor, the Philips IntelliVue Guardian software and the hospital’s EMR system, the organization aims to reduce the time nurses spend on administration.

Self-management for patients

Other hospitals will start projects in the field of home monitoring and self-management for patients, something that IJsselland Hospital in Capelle aan den IJssel, the Netherlands, is already doing with Philips as part of a telemonitoring project for patients with heart failure and COPD. Patients measure their blood pressure and weight at home, and this data is monitored by heart failure nurses in the hospital. Patients also receive additional information and tips on how to manage their condition. The aim is to prevent readmissions and increase patient engagement, something that will be supported by Philips’ patient-centric Engage platform, which provides patient and provider access to an overview of the patient’s health information.

The SAZ has experience with multiparty collaborations to improve healthcare. In 2017 the 28 hospitals started the company BeterDichtbij BV. BeterDichtbij is now used by 35 hospitals in the Netherlands. As part of the strategic collaboration between SAZ a connection will be realized between BeterDichtbij and the Philips Engage platform.

Hot this week

Cartessa Aesthetics Partners with Classys to Bring EVERESSE to the U.S. Market

Classys, which is listed on the KOSDAQ, is one of South Korea's most distinguished aesthetic technology manufacturers, with devices distributed in 80+ markets globally. This partnership marks Classys's official entry into the American marketplace, with Cartessa Aesthetics as the exclusive distributor for EVERESSE, launched under the Volnewmer brand in current global markets.

Stryker Launches Next-Generation of SurgiCount+

Now integrated with Stryker's Triton technology, SurgiCount+ addresses two key challenges: retained surgical sponges and blood loss assessment. Integrating these previously separate digital solutions provides the added benefit of a more efficient, streamlined workflow for hospitals notes Stryker.

Nevro Receives CE Mark In Europe for It’s HFX iQ™ Spinal Cord Stimulation System

Nevro notes HFX iQ is the first and only SCS system with artificial intelligence (AI) technology that combines high-frequency (10 kHz) therapy built on landmark evidence that uses ongoing cloud data insights to deliver personalized pain relief

Recor Medical Reports: CMS Grants Distinct TPT Device Code and Category to Recor Medical for Ultrasound Renal Denervation

The approval of TPT offers incremental reimbursement payments for outpatient procedures performed with ultrasound renal denervation for Medicare fee-for-service beneficiaries. It becomes effective January 1, 2025, and is expected to remain effective for up to three years notes Recor Medical.

Jupiter Endovascular Reports | 1st U.S. Patient Treated with Jupiter Shape-shifting Thrombectomy Device

“Navigation challenges during endovascular procedures are often underappreciated and have led to under-adoption of life-saving procedures, such as pulmonary embolectomy. We have purpose-built our Endoportal Control technology to solve these issues and make important endovascular procedures accessible to more clinicians and their patients who can benefit from them,” said Carl J. St. Bernard, Jupiter Endovascular CEO. “This first case in the U.S. could not have gone better, and appears to validate the safety and performance we are seeing in our currently-enrolling European SPIRARE I study.”